Molteni; Valentina

Patent Applications and Registrations

Patent applications and USPTO patent grants for Molteni; Valentina.The latest application filed is for "1,2,4-oxadiazole derivatives as liver x receptor agonists".

Company Profile

9.51.69

Molteni; Valentina - San Diego CA

*profile and listings may contain filings by different individuals or companies with the same name. Review application materials to confirm ownership/assignment.

Patent Activity

Patent	Date
1,2,4-oxadiazole derivatives as liver X receptor agonists Grant 11,427,586 - Boss , et al. August 30, 2	2022-08-30
5,6-fused-bicyclic compounds and compositions for the treatment of parasitic diseases Grant 11,384,078 - Jiricek , et al. July 12, 2	2022-07-12
1,2,4-oxadiazole Derivatives As Liver X Receptor Agonists App 20220064164 - BOSS; Kelly D. ; et al.	2022-03-03
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20210369716 - BIGGART; Agnes ; et al.	2021-12-02
Compounds and compositions for the treatment of parasitic diseases Grant 11,123,348 - Biggart , et al. September 21, 2	2021-09-21
Compositions And Methods For Modulating Farnesoid X Receptors App 20210253534 - CHIANELLI; Donatella ; et al.	2021-08-19
Compositions and methods for modulating farnesoid X receptors Grant 11,021,446 - Chianelli , et al. June 1, 2	2021-06-01
Compositions And Methods For Modulating Farnesoid X Receptors App 20200247757 - Kind Code	2020-08-06
Compositions and methods for modulating farnesoid X receptors Grant 10,683,271 - Chianelli , et al.	2020-06-16
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20200179391 - BIGGART; Agnes ; et al.	2020-06-11
5,6-fused-bicyclic Compounds And Compositions For The Treatment Of Parasitic Diseases App 20200109142 - Jiricek; Jan ; et al.	2020-04-09
Compounds and compositions for the treatment of parasitic diseases Grant 10,596,175 - Biggart , et al.	2020-03-24
Fused tricyclic pyrazole derivatives useful for farnesoid X receptors Grant 10,351,576 - Chianelli , et al. July 16, 2	2019-07-16
Compositions And Methods For Modulating Farnesoid X Receptors App 20190062283 - CHIANELLI; Donatella ; et al.	2019-02-28
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20190000852 - BIGGART; Agnes ; et al.	2019-01-03
Fused Tricyclic Pyrazole Derivatives Useful For Farnesoid X Receptors App 20180298018 - CHIANELLI; Donatella ; et al.	2018-10-18
Compounds and compositions for the treatment of parasitic diseases Grant 10,085,989 - Biggart , et al. October 2, 2	2018-10-02
Compositions and methods for modulating farnesoid X receptors Grant 10,077,240 - Chianelli , et al. September 18, 2	2018-09-18
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20170333437 - BIGGART; Agnes ; et al.	2017-11-23
Compositions And Methods For Modulating Farnesoid X Receptors App 20170275256 - CHIANELLI; Donatella ; et al.	2017-09-28
Bicyclic heterocycle derivatives for the treatment of pulmonary arterial hypertension Grant 9,751,876 - Bruce , et al. September 5, 2	2017-09-05
Compounds and compositions for the treatment of parasitic diseases Grant 9,700,559 - Biggart , et al. July 11, 2	2017-07-11
Compositions and methods for modulating farnesoid X receptors Grant 9,682,939 - Chianelli , et al. June 20, 2	2017-06-20
Compositions And Methods For Modulating Farnesoid X Receptors App 20160340317 - CHIANELLI; Donatella ; et al.	2016-11-24
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20160303129 - BIGGART; Agnes ; et al.	2016-10-20
Compounds and compositions for the treatment of parasitic diseases Grant 9,303,034 - Biggart , et al. April 5, 2	2016-04-05
Compounds and compositions for the treatment of parasitic diseases Grant 9,296,754 - Liang , et al. March 29, 2	2016-03-29
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20160045505 - JIRICEK; Jan ; et al.	2016-02-18
Compounds and compositions for the treatment of parasitic diseases Grant 9,233,961 - Chatterjee , et al. January 12, 2	2016-01-12
Compounds and compositions as C-kit kinase inhibitors Grant 9,199,981 - Yeh , et al. December 1, 2	2015-12-01
Compounds and compositions for the treatment of parasitic diseases Grant 9,186,361 - Chatterjee , et al. November 17, 2	2015-11-17
Compounds and compositions as TRK inhibitors Grant 9,102,671 - Molteni , et al. August 11, 2	2015-08-11
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20150175613 - BIGGART; Agnes ; et al.	2015-06-25
Compounds and compositions as c-kit kinase inhibitors Grant 9,023,839 - Molteni , et al. May 5, 2	2015-05-05
Compounds And Compositions As C-kit Kinase Inhibitors App 20150051206 - Loren; Jon ; et al.	2015-02-19
Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20150025059 - Bruce; Ian ; et al.	2015-01-22
Compounds And Compositions As C-kit Kinase Inhibitors App 20150011508 - Liu; Xiaodong ; et al.	2015-01-08
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20140275013 - CHATTERJEE; Arnab Kumar ; et al.	2014-09-18
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20140275119 - LIANG; Fang ; et al.	2014-09-18
Compounds And Compositions For The Treatment Of Parasitic Diseases App 20140274926 - CHATTERJEE; Arnab Kumar ; et al.	2014-09-18
Compounds And Compositions As C-kit Kinase Inhibitors App 20140228347 - MOLTENI; Valentina ; et al.	2014-08-14
Compounds And Compositions As Pdgfr Kinase Inhibitors App 20140206682 - Liang; Fang ; et al.	2014-07-24
Compounds and compositions as TRK inhibitors Grant 8,637,516 - Fan , et al. January 28, 2	2014-01-28
Compounds And Compositions As Lxr Modulators App 20130345220 - MOLTENI; Valentina ; et al.	2013-12-26
Compounds And Compositions As Trk Inhibitors App 20130331397 - Molteni; Valentina ; et al.	2013-12-12
Compounds and compositions as c-Kit kinase inhibitors Grant 8,569,283 - Molteni , et al. October 29, 2	2013-10-29
Compounds and compositions as LXR modulators Grant 8,569,345 - Molteni , et al. October 29, 2	2013-10-29
Bicyclic Heterocycle Derivatives For The Treatment Of Pulmonary Arterial Hypertension App 20130237519 - Bruce; Ian ; et al.	2013-09-12
Compounds And Compositions As C-kit Kinase Inhibitors App 20130059832 - MOLTENI; Valentina ; et al.	2013-03-07
Compounds And Compositions As C-kit Kinase Inhibitors App 20130059846 - YEH; Vince ; et al.	2013-03-07
Compounds and compositions as c-kit and PDGFR kinase inhibitors Grant 8,338,417 - Li , et al. December 25, 2	2012-12-25
5-(4-(haloalkoxy)phenyl) pyrimidine-2-amine compounds and compositions as kinase inhibitors Grant 8,293,757 - Molteni , et al. October 23, 2	2012-10-23
2-heteroarylamino-pyrimidine derivatives as kinase inhibitors Grant 8,288,540 - Chianelli , et al. October 16, 2	2012-10-16
Heterocyclic compounds and compositions as c-kit and PDGFR kinase inhibitors Grant 8,278,452 - Chianelli , et al. October 2, 2	2012-10-02
Pyrimidine derivatives and compositions as C-kit and PDGFR kinase inhibitors Grant 8,268,850 - Li , et al. September 18, 2	2012-09-18
Compounds And Compositions As Lxr Modulators App 20120214812 - MOLTENI; VALENTINA ; et al.	2012-08-23
Compounds and compositions as LXR modulators Grant 8,158,662 - Molteni , et al. April 17, 2	2012-04-17
Compounds And Compositions As Trk Inhibitors App 20120065184 - Fan; Yi ; et al.	2012-03-15
Compositions and methods for modulating c-kit and PDGFR receptors Grant 8,106,068 - Liu , et al. January 31, 2	2012-01-31
5- (4- (haloalkoxy) Phenyl) Pyrimidine-2-amine Compounds And Compositions As Kinase Inhibitors App 20110301175 - Molteni; Valentina ; et al.	2011-12-08
Heterocyclic Compounds And Compositions As C-kit And Pdgfr Kinase Inhibitors App 20110183997 - Chianelli; Donatella ; et al.	2011-07-28
2-heteroarylamino-pyrimidine Derivatives As Kinase Inhibitors App 20110053952 - Chianelli; Donatella ; et al.	2011-03-03
Compounds and compositions as LXR modulators Grant 7,846,949 - Molteni , et al. December 7, 2	2010-12-07
Compounds And Compositions As C-kit And Pdgfr Kinase Inhibitors App 20100234406 - Li; Xiaolin ; et al.	2010-09-16
Pyrimidine Derivatives And Compositions As C-kit And Pdgfr Kinase Inhibitors App 20100190811 - Li; Xiaolin ; et al.	2010-07-29
Compounds And Compositions As C-kit And Pdgfr Kinase Inhibitors App 20100184791 - Li; Xiaolin ; et al.	2010-07-22
Compositions And Methods For Modulating C-kit And Pdgfr Receptors App 20100081656 - Chianelli; Donatella ; et al.	2010-04-01
Compositions and methods for modulating c-kit and PDGFR receptors Grant 7,678,792 - Chianelli , et al. March 16, 2	2010-03-16
Compounds And Compositions As Protein Kinase Inhibitors App 20100048539 - Chianelli; Donatella ; et al.	2010-02-25
Compounds and compositions as lxr modulators App 20090325981 - Molteni; Valentina ; et al.	2009-12-31
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,638,523 - Molteni , et al. December 29, 2	2009-12-29
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20090264649 - Molteni; Valentina ; et al.	2009-10-22
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,592,349 - Molteni , et al. September 22, 2	2009-09-22
Bicyclic compounds and compositions as PDF inhibitors Grant 7,579,363 - Molteni , et al. August 25, 2	2009-08-25
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,563,894 - Molteni , et al. July 21, 2	2009-07-21
Spiro Imidozole Derivatives As Ppar Modulators App 20090137610 - Epple; Robert ; et al.	2009-05-28
Diarylamine-containing compounds and compositions, and their use as modulators of c-kit receptors Grant 7,514,447 - Molteni , et al. April 7, 2	2009-04-07
Compounds And Compositions As Lxr Modulators App 20090062260 - Molteni; Valentina ; et al.	2009-03-05
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20090012094 - Molteni; Valentina ; et al.	2009-01-08
Compositions And Methods For Modulating C-kit And Pdgfr Receptors App 20080176846 - Chianelli; Donatella ; et al.	2008-07-24
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080167308 - Molteni; Valentina ; et al.	2008-07-10
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080139597 - Molteni; Valentina ; et al.	2008-06-12
Diarylamine-containing Compounds And Compositions, And Their Use As Modulators Of C-kit Receptors App 20080139559 - Molteni; Valentina ; et al.	2008-06-12
Compounds and Compositions as Lxr Modulators App 20070293547 - Molteni; Valentina ; et al.	2007-12-20
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands Grant 7,297,708 - Termin , et al. November 20, 2	2007-11-20
Bicyclic Compounds And Compositions As Pdf Inhibitors App 20070259852 - Molteni; Valentina ; et al.	2007-11-08
Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands Grant 7,276,526 - Termin , et al. October 2, 2	2007-10-02
Bicyclic compounds and compositions as PDF inhibitors Grant 7,253,164 - Molteni , et al. August 7, 2	2007-08-07
Diarylamine-Containing Compounds and Compositions, and their use as Modulators of C-Kit Receptors App 20070149538 - Molteni; Valentina ; et al.	2007-06-28
Bicyclic compounds and compostions as PDF inhibitors App 20050197326 - Molteni, Valentina ; et al.	2005-09-08
Heteroaromatic substituted cyclopropane as corticotropin releasing hormone ligands App 20030229091 - Termin, Andreas ; et al.	2003-12-11
Substituted thiazoles and oxazoles as corticotropin releasing hormone ligands App 20030114502 - Termin, Andreas ; et al.	2003-06-19

uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.